Coherus market cap
WebMar 17, 2024 · See the latest Coherus BioSciences Inc stock price (NASDAQ:CHRS), related news, valuation, dividends and more to help you make your investing decisions. WebJun 18, 2024 · CHRS has a market cap of $1.08bn and a cash balance of $399mn. Last year, the company had nearly half a billion dollar in product revenue. Bottom line The standard gripe of investors with CHRS...
Coherus market cap
Did you know?
WebApr 12, 2024 · According to analysts' consensus price target of $16.50, Coherus BioSciences has a forecasted upside of 120.9% from its current price of $7.47. Amount of Analyst Coverage Coherus BioSciences has … WebCurrent and historical earnings charts for Coherus BioSciences . As of April 2024 Coherus BioSciences 's TTM earnings are -$0.26 B. companies: 7,323 total market cap: $86.813 T. ... The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the ...
Web26 rows · Mar 31, 2024 · Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares … WebJan 31, 2024 · Coherus has a market cap valuation of $633m at the time of writing, yet the company - according to a presentation delivered at this year's JP Morgan Healthcare …
Web2 days ago · Get a real-time Coherus BioSciences, Inc. (CHRS) stock price quote with breaking news, financials, statistics, charts and more. ... Market Cap: 620.96M: Revenue (ttm) 211.04M: Net Income (ttm)-291.75M: Shares Out ... 3, 2024: About CHRS. Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno … Web$7.66 (As of Thursday Closing) General Information Description Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of …
WebCoherus Biosciences Stock Price Today (NASDAQ: CHRS) Quote, Market Cap, Chart WallStreetZen Coherus Biosciences Inc Stock Add to Watchlist Overview Forecast …
WebFind real-time CHRS - Coherus BioSciences Inc stock quotes, company profile, news and forecasts from CNN Business. CHRS - Coherus BioSciences Inc Stock quote - … island parkwayWebAbout Coherus Immuno-oncology Dedicated to Improving Patient Lives by Expanding Access to Life-Changing Biologic Medicines Our approved products span multiple therapeutic areas including oncology, … island park vacation rentals idahoWebMar 28, 2024 · The Coherus BioSciences stock price gained 7.00% on the last trading day (Tuesday, 28th Mar 2024), rising from $6.00 to $6.42.During the last trading day the stock fluctuated 4.30% from a day low at $6.28 to a day high of $6.55.The price has risen in 5 of the last 10 days and is up by 1.1% over the past 2 weeks. Volume has increased on the … island park west marineWebCoherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified … key term index for the 2020 rcw/wacWebAbout Coherus. Leadership Team; Board of Directors; Scientific Advisory Board; Immuno-oncology Scientific Advisory Board; Commercial Advisory Committee; Contact Us; … key term maintenance trainingWebAug 19, 2024 · Coherus’ market cap is US$1 billion, the forward P/E one year is -4.46, the EPS is US$-2.32, and the 52-week highest and the lowest stock price of the company was US$22.22 and US$12.21. The stock fell 18.64 percent YTD. Also read: Check out these fastest-growing small-cap healthcare stocks key term extractionWebApr 12, 2024 · The average twelve-month price prediction for Coherus BioSciences is $16.50 with a high price target of $26.00 and a low price target of $11.00. Do Wall Street analysts like Coherus BioSciences more than its competitors? Analysts like Coherus BioSciences more than other Medical companies. island park wichita